Detailed View
AUPH - Aurinia Pharmaceuticals Inc
Latest filing: 2026-06-30 | Reporting: gaap
Market Cap
2,142,123,904
Adj EBIT (TTM)
93,692,000
Enterprise Value
1,759,422,904
Last Price
16.10
Earnings Yield
5.33%
Return on Capital
13.60%
Capital
688,991,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-06-30 | 10-Q | 2026 | 83,220,000 | 46,341,000 |
| 2026-03-31 | 10-Q | 2026 | 77,705,000 | 41,422,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | -128,827,000 | -38,436,000 |
| 2025-09-30 | 10-Q | 2025 | 73,468,000 | 29,745,000 |
| 2025-06-30 | 10-Q | 2025 | 70,008,000 | 20,083,000 |
| 2025-03-31 | 10-Q | 2025 | 62,465,000 | 21,847,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | -115,399,000 | 1,349,000 |
| 2024-09-30 | 10-Q | 2024 | 67,771,000 | 11,748,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.